GNAPHALIUM POLYCEPHALUM is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Rxhomeo Private Limited D.b.a. Rxhomeo, Inc. The primary component is Pseudognaphalium Obtusifolium.
| Product ID | 15631-0592_d58d32d0-d18b-42d8-8f14-7253beaf6271 |
| NDC | 15631-0592 |
| Product Type | Human Otc Drug |
| Proprietary Name | GNAPHALIUM POLYCEPHALUM |
| Generic Name | Gnaphalium Polycephalum |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2016-01-07 |
| Marketing Category | UNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC |
| Labeler Name | Rxhomeo Private Limited d.b.a. Rxhomeo, Inc |
| Substance Name | PSEUDOGNAPHALIUM OBTUSIFOLIUM |
| Active Ingredient Strength | 1 [hp_X]/1 |
| NDC Exclude Flag | E |
| Listing Certified Through | 2018-12-31 |
| Marketing Start Date | 2016-01-07 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | unapproved homeopathic |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2016-01-07 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | unapproved homeopathic |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2016-01-07 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | unapproved homeopathic |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2016-01-07 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | unapproved homeopathic |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2016-01-07 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | unapproved homeopathic |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2016-01-07 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | unapproved homeopathic |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2016-01-07 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | unapproved homeopathic |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2016-01-07 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | unapproved homeopathic |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2016-01-07 |
| Inactivation Date | 2020-01-31 |
| Ingredient | Strength |
|---|---|
| PSEUDOGNAPHALIUM OBTUSIFOLIUM | 1 [hp_X]/1 |
| SPL SET ID: | bbf5205f-9294-40ec-b094-666f5d6a7fb0 |
| Manufacturer | |
| UNII | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0220-2306 | Gnaphalium polycephalum | PSEUDOGNAPHALIUM OBTUSIFOLIUM |
| 0220-2307 | Gnaphalium polycephalum | PSEUDOGNAPHALIUM OBTUSIFOLIUM |
| 0220-2310 | Gnaphalium polycephalum | PSEUDOGNAPHALIUM OBTUSIFOLIUM |
| 0220-2313 | Gnaphalium polycephalum | PSEUDOGNAPHALIUM OBTUSIFOLIUM |
| 15631-0208 | GNAPHALIUM POLYCEPHALUM | GNAPHALIUM POLYCEPHALUM |
| 15631-0592 | GNAPHALIUM POLYCEPHALUM | GNAPHALIUM POLYCEPHALUM |
| 37662-0928 | Gnaphalium Polycephalum | Gnaphalium Polycephalum |
| 37662-0929 | Gnaphalium Polycephalum | Gnaphalium Polycephalum |
| 37662-0930 | Gnaphalium Polycephalum | Gnaphalium Polycephalum |
| 37662-0931 | Gnaphalium Polycephalum | Gnaphalium Polycephalum |
| 37662-0932 | Gnaphalium Polycephalum | Gnaphalium Polycephalum |
| 37662-0933 | Gnaphalium Polycephalum | Gnaphalium Polycephalum |
| 37662-0934 | Gnaphalium Polycephalum | Gnaphalium Polycephalum |
| 68428-409 | Gnaphalium polycephalum | PSEUDOGNAPHALIUM OBTUSIFOLIUM |
| 71919-321 | Gnaphalium polycephalum | PSEUDOGNAPHALIUM OBTUSIFOLIUM |